These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12056930)

  • 1. Clinical features and disease haplotypes of individuals with the N279K tau gene mutation: a comparison of the pallidopontonigral degeneration kindred and a French family.
    Tsuboi Y; Uitti RJ; Delisle MB; Ferreira JJ; Brefel-Courbon C; Rascol O; Ghetti B; Murrell JR; Hutton M; Baker M; Wszolek ZK
    Arch Neurol; 2002 Jun; 59(6):943-50. PubMed ID: 12056930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutation at codon 279 (N279K) in exon 10 of the Tau gene causes a tauopathy with dementia and supranuclear palsy.
    Delisle MB; Murrell JR; Richardson R; Trofatter JA; Rascol O; Soulages X; Mohr M; Calvas P; Ghetti B
    Acta Neuropathol; 1999 Jul; 98(1):62-77. PubMed ID: 10412802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two brothers with frontotemporal dementia and parkinsonism with an N279K mutation of the tau gene.
    Arima K; Kowalska A; Hasegawa M; Mukoyama M; Watanabe R; Kawai M; Takahashi K; Iwatsubo T; Tabira T; Sunohara N
    Neurology; 2000 May; 54(9):1787-95. PubMed ID: 10802785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontotemporal dementia-associated N279K tau mutant disrupts subcellular vesicle trafficking and induces cellular stress in iPSC-derived neural stem cells.
    Wren MC; Zhao J; Liu CC; Murray ME; Atagi Y; Davis MD; Fu Y; Okano HJ; Ogaki K; Strongosky AJ; Tacik P; Rademakers R; Ross OA; Dickson DW; Wszolek ZK; Kanekiyo T; Bu G
    Mol Neurodegener; 2015 Sep; 10():46. PubMed ID: 26373282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical-pathologic study of biomarkers in FTDP-17 (PPND family with N279K tau mutation).
    Arvanitakis Z; Witte RJ; Dickson DW; Tsuboi Y; Uitti RJ; Slowinski J; Hutton ML; Lin SC; Boeve BF; Cheshire WP; Pooley RA; Liss JM; Caviness JN; Strongosky AJ; Wszolek ZK
    Parkinsonism Relat Disord; 2007 May; 13(4):230-9. PubMed ID: 17196872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early and pre-symptomatic neuropsychological dysfunction in the PPND family with the N279K tau mutation.
    Ferman TJ; McRae CA; Arvanitakis Z; Tsuboi Y; Vo A; Wszolek ZK
    Parkinsonism Relat Disord; 2003 Jun; 9(5):265-70. PubMed ID: 12781592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurodegenerative disease associated with a mutation of codon 279 (N279K) in exon 10 of Tau protein].
    Delisle MB; Uro-Coste E; Murrell JR; Rascol O; Ghetti B
    Bull Acad Natl Med; 2000; 184(4):799-809; discussion 809-11. PubMed ID: 10989564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and genetic studies of families with the tau N279K mutation (FTDP-17).
    Tsuboi Y; Baker M; Hutton ML; Uitti RJ; Rascol O; Delisle MB; Soulages X; Murrell JR; Ghetti B; Yasuda M; Komure O; Kuno S; Arima K; Sunohara N; Kobayashi T; Mizuno Y; Wszolek ZK
    Neurology; 2002 Dec; 59(11):1791-3. PubMed ID: 12473774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tau N279K exon 10 splicing mutation recapitulates frontotemporal dementia and parkinsonism linked to chromosome 17 tauopathy in a mouse model.
    Dawson HN; Cantillana V; Chen L; Vitek MP
    J Neurosci; 2007 Aug; 27(34):9155-68. PubMed ID: 17715352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of chromosome 17 tauopathies.
    Hutton M
    Ann N Y Acad Sci; 2000; 920():63-73. PubMed ID: 11193178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Japanese contribution to the understanding of frontotemporal dementia and parkinsonism linked to chromosome 17(FTDP-17)].
    Tsuboi Y; Wszolek ZK; Mizuno Y; Kobayashi T; Yasuda M; Yamada T
    No To Shinkei; 2003 Feb; 55(2):107-19. PubMed ID: 12684990
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frontotemporal dementia and parkinsonism with the P301S tau gene mutation in a Jewish family.
    Lossos A; Reches A; Gal A; Newman JP; Soffer D; Gomori JM; Boher M; Ekstein D; Biran I; Meiner Z; Abramsky O; Rosenmann H
    J Neurol; 2003 Jun; 250(6):733-40. PubMed ID: 12796837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lrrk2 and chronic inflammation are linked to pallido-ponto-nigral degeneration caused by the N279K tau mutation.
    Miklossy J; Qing H; Guo JP; Yu S; Wszolek ZK; Calne D; McGeer EG; McGeer PL
    Acta Neuropathol; 2007 Sep; 114(3):243-54. PubMed ID: 17639429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical heterogeneity of frontotemporal dementia and Parkinsonism linked to chromosome 17 caused by MAPT N279K mutation in relation to tau positron emission tomography features.
    Ikeda A; Shimada H; Nishioka K; Takanashi M; Hayashida A; Li Y; Yoshino H; Funayama M; Ueno Y; Hatano T; Sahara N; Suhara T; Higuchi M; Hattori N
    Mov Disord; 2019 Apr; 34(4):568-574. PubMed ID: 30773680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.
    Stanford PM; Halliday GM; Brooks WS; Kwok JB; Storey CE; Creasey H; Morris JG; Fulham MJ; Schofield PR
    Brain; 2000 May; 123 ( Pt 5)():880-93. PubMed ID: 10775534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in the understanding of tau protein and movement disorders.
    Arvanitakis Z; Wszolek ZK
    Curr Opin Neurol; 2001 Aug; 14(4):491-7. PubMed ID: 11470966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of dementia parkinsonism resembling progressive supranuclear palsy due to mutation in the tau protein gene.
    Soliveri P; Rossi G; Monza D; Tagliavini F; Piacentini S; Albanese A; Bugiani O; Girotti F
    Arch Neurol; 2003 Oct; 60(10):1454-6. PubMed ID: 14568818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial atypical progressive supranuclear palsy associated with homozigosity for the delN296 mutation in the tau gene.
    Pastor P; Pastor E; Carnero C; Vela R; García T; Amer G; Tolosa E; Oliva R
    Ann Neurol; 2001 Feb; 49(2):263-7. PubMed ID: 11220749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.
    Clark LN; Poorkaj P; Wszolek Z; Geschwind DH; Nasreddine ZS; Miller B; Li D; Payami H; Awert F; Markopoulou K; Andreadis A; D'Souza I; Lee VM; Reed L; Trojanowski JQ; Zhukareva V; Bird T; Schellenberg G; Wilhelmsen KC
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13103-7. PubMed ID: 9789048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.